id	sid	tid	token	lemma	pos
ffhd-863	1	1	effects	effect	NOUN
ffhd-863	1	2	of	of	ADP
ffhd-863	1	3	luteolin	luteolin	PROPN
ffhd-863	1	4	-	-	PUNCT
ffhd-863	1	5	rich	rich	ADJ
ffhd-863	1	6	chrysanthemum	chrysanthemum	NOUN
ffhd-863	1	7	flower	flower	NOUN
ffhd-863	1	8	extract	extract	VERB
ffhd-863	1	9	on	on	ADP
ffhd-863	1	10	purine	purine	NOUN
ffhd-863	1	11	base	base	NOUN
ffhd-863	1	12	absorption	absorption	NOUN
ffhd-863	1	13	and	and	CCONJ
ffhd-863	1	14	blood	blood	NOUN
ffhd-863	1	15	uric	uric	ADJ
ffhd-863	1	16	acid	acid	NOUN
ffhd-863	1	17	in	in	ADP
ffhd-863	1	18	japanese	japanese	ADJ
ffhd-863	1	19	subjects	subject	NOUN
ffhd-863	1	20	|	|	ADV
ffhd-863	1	21	functional	functional	ADJ
ffhd-863	1	22	foods	food	NOUN
ffhd-863	1	23	in	in	ADP
ffhd-863	1	24	health	health	NOUN
ffhd-863	1	25	and	and	CCONJ
ffhd-863	1	26	disease	disease	PROPN
ffhd-863	1	27	online	online	PROPN
ffhd-863	1	28	issn	issn	PROPN
ffhd-863	1	29	:	:	PUNCT
ffhd-863	1	30	2160	2160	NUM
ffhd-863	1	31	-	-	SYM
ffhd-863	1	32	3855	3855	NUM
ffhd-863	1	33	;	;	PUNCT
ffhd-863	1	34	print	print	NOUN
ffhd-863	1	35	issn	issn	PROPN
ffhd-863	1	36	:	:	PUNCT
ffhd-863	1	37	2378	2378	NUM
ffhd-863	1	38	-	-	SYM
ffhd-863	1	39	7007	7007	NUM
ffhd-863	1	40	skip	skip	NOUN
ffhd-863	1	41	to	to	ADP
ffhd-863	1	42	main	main	ADJ
ffhd-863	1	43	content	content	NOUN
ffhd-863	1	44	skip	skip	ADJ
ffhd-863	1	45	to	to	ADP
ffhd-863	1	46	main	main	ADJ
ffhd-863	1	47	navigation	navigation	NOUN
ffhd-863	1	48	menu	menu	NOUN
ffhd-863	1	49	skip	skip	VERB
ffhd-863	1	50	to	to	PART
ffhd-863	1	51	site	site	VERB
ffhd-863	1	52	footer	footer	ADJ
ffhd-863	1	53	open	open	ADJ
ffhd-863	1	54	menu	menu	NOUN
ffhd-863	1	55	functional	functional	ADJ
ffhd-863	1	56	foods	food	NOUN
ffhd-863	1	57	in	in	ADP
ffhd-863	1	58	health	health	NOUN
ffhd-863	1	59	and	and	CCONJ
ffhd-863	1	60	disease	disease	PROPN
ffhd-863	1	61	online	online	PROPN
ffhd-863	1	62	issn	issn	PROPN
ffhd-863	1	63	:	:	PUNCT
ffhd-863	1	64	2160	2160	NUM
ffhd-863	1	65	-	-	SYM
ffhd-863	1	66	3855	3855	NUM
ffhd-863	1	67	;	;	PUNCT
ffhd-863	1	68	print	print	NOUN
ffhd-863	1	69	issn	issn	PROPN
ffhd-863	1	70	:	:	PUNCT
ffhd-863	1	71	2378	2378	NUM
ffhd-863	1	72	-	-	SYM
ffhd-863	1	73	7007	7007	NUM
ffhd-863	1	74	home	home	NOUN
ffhd-863	1	75	food	food	NOUN
ffhd-863	1	76	science	science	NOUN
ffhd-863	1	77	publisher	publisher	NOUN
ffhd-863	1	78	functional	functional	ADJ
ffhd-863	1	79	food	food	NOUN
ffhd-863	1	80	center	center	NOUN
ffhd-863	1	81	current	current	ADJ
ffhd-863	1	82	archives	archive	NOUN
ffhd-863	1	83	about	about	ADP
ffhd-863	1	84	about	about	ADP
ffhd-863	1	85	the	the	DET
ffhd-863	1	86	journal	journal	NOUN
ffhd-863	1	87	aims	aim	VERB
ffhd-863	1	88	and	and	CCONJ
ffhd-863	1	89	scope	scope	NOUN
ffhd-863	1	90	contact	contact	NOUN
ffhd-863	1	91	editing	edit	VERB
ffhd-863	1	92	services	service	NOUN
ffhd-863	1	93	editorial	editorial	ADJ
ffhd-863	1	94	team	team	NOUN
ffhd-863	1	95	express	express	VERB
ffhd-863	1	96	peer	peer	NOUN
ffhd-863	1	97	review	review	NOUN
ffhd-863	1	98	graphical	graphical	ADJ
ffhd-863	1	99	abstract	abstract	ADJ
ffhd-863	1	100	journal	journal	NOUN
ffhd-863	1	101	insights	insight	VERB
ffhd-863	1	102	privacy	privacy	NOUN
ffhd-863	1	103	statement	statement	NOUN
ffhd-863	1	104	submissions	submission	NOUN
ffhd-863	1	105	announcements	announcement	NOUN
ffhd-863	1	106	search	search	NOUN
ffhd-863	1	107	search	search	NOUN
ffhd-863	1	108	register	register	NOUN
ffhd-863	1	109	login	login	NOUN
ffhd-863	1	110	home	home	NOUN
ffhd-863	1	111	/	/	SYM
ffhd-863	1	112	archives	archive	NOUN
ffhd-863	1	113	/	/	SYM
ffhd-863	1	114	vol	vol	NOUN
ffhd-863	1	115	.	.	PROPN
ffhd-863	2	1	12	12	NUM
ffhd-863	2	2	no	no	NOUN
ffhd-863	2	3	.	.	NOUN
ffhd-863	2	4	1	1	NUM
ffhd-863	2	5	(	(	PUNCT
ffhd-863	2	6	2022	2022	NUM
ffhd-863	2	7	):	):	PUNCT
ffhd-863	2	8	january	january	PROPN
ffhd-863	2	9	2022	2022	NUM
ffhd-863	2	10	/	/	SYM
ffhd-863	2	11	research	research	NOUN
ffhd-863	2	12	articles	article	NOUN
ffhd-863	2	13	effects	effect	NOUN
ffhd-863	2	14	of	of	ADP
ffhd-863	2	15	luteolin	luteolin	PROPN
ffhd-863	2	16	-	-	PUNCT
ffhd-863	2	17	rich	rich	ADJ
ffhd-863	2	18	chrysanthemum	chrysanthemum	NOUN
ffhd-863	2	19	flower	flower	NOUN
ffhd-863	2	20	extract	extract	VERB
ffhd-863	2	21	on	on	ADP
ffhd-863	2	22	purine	purine	NOUN
ffhd-863	2	23	base	base	NOUN
ffhd-863	2	24	absorption	absorption	NOUN
ffhd-863	2	25	and	and	CCONJ
ffhd-863	2	26	blood	blood	NOUN
ffhd-863	2	27	uric	uric	ADJ
ffhd-863	2	28	acid	acid	NOUN
ffhd-863	2	29	in	in	ADP
ffhd-863	2	30	japanese	japanese	ADJ
ffhd-863	2	31	subjects	subject	NOUN
ffhd-863	2	32	authors	author	NOUN
ffhd-863	2	33	tsuyoshi	tsuyoshi	PROPN
ffhd-863	2	34	takara	takara	PROPN
ffhd-863	2	35	takara	takara	PROPN
ffhd-863	2	36	clinic	clinic	PROPN
ffhd-863	2	37	,	,	PUNCT
ffhd-863	2	38	medical	medical	ADJ
ffhd-863	2	39	corporation	corporation	NOUN
ffhd-863	2	40	seishinkai	seishinkai	PROPN
ffhd-863	2	41	kazuo	kazuo	PROPN
ffhd-863	2	42	yamamoto	yamamoto	PROPN
ffhd-863	2	43	orthomedico	orthomedico	PROPN
ffhd-863	2	44	inc	inc	PROPN
ffhd-863	2	45	.	.	PROPN
ffhd-863	2	46	naoko	naoko	PROPN
ffhd-863	2	47	suzuki	suzuki	PROPN
ffhd-863	2	48	orthomedico	orthomedico	PROPN
ffhd-863	2	49	inc	inc	PROPN
ffhd-863	2	50	.	.	PROPN
ffhd-863	2	51	shin	shin	PROPN
ffhd-863	2	52	-	-	PUNCT
ffhd-863	2	53	ichiro	ichiro	PROPN
ffhd-863	2	54	yamashita	yamashita	PROPN
ffhd-863	2	55	orthomedico	orthomedico	PROPN
ffhd-863	2	56	inc	inc	PROPN
ffhd-863	2	57	.	.	PROPN
ffhd-863	2	58	shin	shin	PROPN
ffhd-863	2	59	-	-	PUNCT
ffhd-863	2	60	ichiro	ichiro	PROPN
ffhd-863	2	61	iio	iio	PROPN
ffhd-863	2	62	orthomedico	orthomedico	PROPN
ffhd-863	2	63	inc	inc	PROPN
ffhd-863	2	64	.	.	PROPN
ffhd-863	3	1	toshihiro	toshihiro	PROPN
ffhd-863	3	2	kakinuma	kakinuma	PROPN
ffhd-863	3	3	asami	asami	PROPN
ffhd-863	3	4	baba	baba	PROPN
ffhd-863	3	5	orthomedico	orthomedico	PROPN
ffhd-863	3	6	inc	inc	PROPN
ffhd-863	3	7	.	.	PROPN
ffhd-863	3	8	shogo	shogo	PROPN
ffhd-863	3	9	takeda	takeda	PROPN
ffhd-863	3	10	oryza	oryza	PROPN
ffhd-863	3	11	oil	oil	PROPN
ffhd-863	3	12	&	&	CCONJ
ffhd-863	3	13	fat	fat	PROPN
ffhd-863	3	14	chemical	chemical	PROPN
ffhd-863	3	15	co.	co.	PROPN
ffhd-863	3	16	ltd	ltd	PROPN
ffhd-863	3	17	.	.	PROPN
ffhd-863	3	18	wakana	wakana	PROPN
ffhd-863	3	19	yamada	yamada	PROPN
ffhd-863	3	20	masafumi	masafumi	PROPN
ffhd-863	3	21	nagata	nagata	PROPN
ffhd-863	3	22	minamimachi	minamimachi	PROPN
ffhd-863	3	23	clinic	clinic	PROPN
ffhd-863	3	24	hiroshi	hiroshi	PROPN
ffhd-863	3	25	shimoda	shimoda	PROPN
ffhd-863	3	26	oryza	oryza	PROPN
ffhd-863	3	27	oil	oil	PROPN
ffhd-863	3	28	&	&	CCONJ
ffhd-863	3	29	fat	fat	PROPN
ffhd-863	3	30	chemical	chemical	PROPN
ffhd-863	3	31	co.	co.	PROPN
ffhd-863	3	32	ltd	ltd	PROPN
ffhd-863	3	33	.	.	PROPN
ffhd-863	4	1	doi	doi	PROPN
ffhd-863	4	2	:	:	PUNCT
ffhd-863	4	3	https://doi.org/10.31989/ffhd.v12i1.863	https://doi.org/10.31989/ffhd.v12i1.863	NOUN
ffhd-863	4	4	abstract	abstract	ADJ
ffhd-863	4	5	background	background	NOUN
ffhd-863	4	6	and	and	CCONJ
ffhd-863	4	7	objective	objective	NOUN
ffhd-863	4	8	:	:	PUNCT
ffhd-863	4	9	 	 	SPACE
ffhd-863	4	10	chrysanthemum	chrysanthemum	NOUN
ffhd-863	4	11	flowers	flower	NOUN
ffhd-863	4	12	are	be	AUX
ffhd-863	4	13	consumed	consume	VERB
ffhd-863	4	14	as	as	ADP
ffhd-863	4	15	fresh	fresh	ADJ
ffhd-863	4	16	condiments	condiment	NOUN
ffhd-863	4	17	,	,	PUNCT
ffhd-863	4	18	herbal	herbal	ADJ
ffhd-863	4	19	teas	tea	NOUN
ffhd-863	4	20	,	,	PUNCT
ffhd-863	4	21	and	and	CCONJ
ffhd-863	4	22	processed	process	VERB
ffhd-863	4	23	foods	food	NOUN
ffhd-863	4	24	in	in	ADP
ffhd-863	4	25	japan	japan	PROPN
ffhd-863	4	26	and	and	CCONJ
ffhd-863	4	27	taiwan	taiwan	PROPN
ffhd-863	4	28	.	.	PUNCT
ffhd-863	5	1	they	they	PRON
ffhd-863	5	2	contain	contain	VERB
ffhd-863	5	3	luteolin	luteolin	ADV
ffhd-863	5	4	as	as	ADP
ffhd-863	5	5	a	a	DET
ffhd-863	5	6	major	major	ADJ
ffhd-863	5	7	polyphenol	polyphenol	NOUN
ffhd-863	5	8	and	and	CCONJ
ffhd-863	5	9	are	be	AUX
ffhd-863	5	10	traditionally	traditionally	ADV
ffhd-863	5	11	used	use	VERB
ffhd-863	5	12	for	for	ADP
ffhd-863	5	13	eye	eye	NOUN
ffhd-863	5	14	care	care	NOUN
ffhd-863	5	15	.	.	PUNCT
ffhd-863	5	16	 	 	SPACE
ffhd-863	6	1	we	we	PRON
ffhd-863	6	2	previously	previously	ADV
ffhd-863	6	3	demonstrated	demonstrate	VERB
ffhd-863	6	4	that	that	SCONJ
ffhd-863	6	5	the	the	DET
ffhd-863	6	6	ingestion	ingestion	NOUN
ffhd-863	6	7	of	of	ADP
ffhd-863	6	8	chrysanthemum	chrysanthemum	ADJ
ffhd-863	6	9	flower	flower	NOUN
ffhd-863	6	10	extract	extract	NOUN
ffhd-863	6	11	(	(	PUNCT
ffhd-863	6	12	cfe	cfe	NOUN
ffhd-863	6	13	)	)	PUNCT
ffhd-863	6	14	for	for	ADP
ffhd-863	6	15	1	1	NUM
ffhd-863	6	16	month	month	NOUN
ffhd-863	6	17	reduced	reduce	VERB
ffhd-863	6	18	serum	serum	NOUN
ffhd-863	6	19	uric	uric	ADJ
ffhd-863	6	20	acid	acid	PROPN
ffhd-863	6	21	levels	level	NOUN
ffhd-863	6	22	.	.	PUNCT
ffhd-863	7	1	however	however	ADV
ffhd-863	7	2	,	,	PUNCT
ffhd-863	7	3	the	the	DET
ffhd-863	7	4	findings	finding	NOUN
ffhd-863	7	5	obtained	obtain	VERB
ffhd-863	7	6	were	be	AUX
ffhd-863	7	7	considered	consider	VERB
ffhd-863	7	8	to	to	PART
ffhd-863	7	9	be	be	AUX
ffhd-863	7	10	biased	bias	VERB
ffhd-863	7	11	because	because	SCONJ
ffhd-863	7	12	the	the	DET
ffhd-863	7	13	study	study	NOUN
ffhd-863	7	14	was	be	AUX
ffhd-863	7	15	performed	perform	VERB
ffhd-863	7	16	by	by	ADP
ffhd-863	7	17	a	a	DET
ffhd-863	7	18	cfe	cfe	NOUN
ffhd-863	7	19	manufacturer	manufacturer	NOUN
ffhd-863	7	20	.	.	PUNCT
ffhd-863	8	1	therefore	therefore	ADV
ffhd-863	8	2	,	,	PUNCT
ffhd-863	8	3	we	we	PRON
ffhd-863	8	4	herein	herein	VERB
ffhd-863	8	5	conducted	conduct	VERB
ffhd-863	8	6	a	a	DET
ffhd-863	8	7	clinical	clinical	ADJ
ffhd-863	8	8	trial	trial	NOUN
ffhd-863	8	9	on	on	ADP
ffhd-863	8	10	cfe	cfe	NOUN
ffhd-863	8	11	on	on	ADP
ffhd-863	8	12	a	a	DET
ffhd-863	8	13	larger	large	ADJ
ffhd-863	8	14	scale	scale	NOUN
ffhd-863	8	15	and	and	CCONJ
ffhd-863	8	16	examined	examine	VERB
ffhd-863	8	17	its	its	PRON
ffhd-863	8	18	effects	effect	NOUN
ffhd-863	8	19	on	on	ADP
ffhd-863	8	20	purine	purine	NOUN
ffhd-863	8	21	base	base	NOUN
ffhd-863	8	22	absorption	absorption	NOUN
ffhd-863	8	23	from	from	ADP
ffhd-863	8	24	the	the	DET
ffhd-863	8	25	intestines	intestine	NOUN
ffhd-863	8	26	,	,	PUNCT
ffhd-863	8	27	which	which	PRON
ffhd-863	8	28	represents	represent	VERB
ffhd-863	8	29	an	an	DET
ffhd-863	8	30	effective	effective	ADJ
ffhd-863	8	31	approach	approach	NOUN
ffhd-863	8	32	for	for	ADP
ffhd-863	8	33	reducing	reduce	VERB
ffhd-863	8	34	serum	serum	NOUN
ffhd-863	8	35	uric	uric	ADJ
ffhd-863	8	36	acid	acid	NOUN
ffhd-863	8	37	levels	level	NOUN
ffhd-863	8	38	.	.	PUNCT
ffhd-863	8	39	  	  	SPACE
ffhd-863	9	1	methods	method	NOUN
ffhd-863	9	2	:	:	PUNCT
ffhd-863	9	3	 	 	SPACE
ffhd-863	9	4	both	both	DET
ffhd-863	9	5	studies	study	NOUN
ffhd-863	9	6	were	be	AUX
ffhd-863	9	7	performed	perform	VERB
ffhd-863	9	8	as	as	ADP
ffhd-863	9	9	randomized	randomized	ADJ
ffhd-863	9	10	,	,	PUNCT
ffhd-863	9	11	double	double	ADJ
ffhd-863	9	12	-	-	PUNCT
ffhd-863	9	13	blind	blind	ADJ
ffhd-863	9	14	,	,	PUNCT
ffhd-863	9	15	placebo	placebo	NOUN
ffhd-863	9	16	-	-	PUNCT
ffhd-863	9	17	controlled	control	VERB
ffhd-863	9	18	trials	trial	NOUN
ffhd-863	9	19	and	and	CCONJ
ffhd-863	9	20	cfe	cfe	NOUN
ffhd-863	9	21	(	(	PUNCT
ffhd-863	9	22	100	100	NUM
ffhd-863	9	23	mg	mg	NOUN
ffhd-863	9	24	)	)	PUNCT
ffhd-863	9	25	containing	contain	VERB
ffhd-863	9	26	1	1	NUM
ffhd-863	9	27	mg	mg	ADP
ffhd-863	9	28	of	of	ADP
ffhd-863	9	29	luteolin	luteolin	PROPN
ffhd-863	9	30	 	 	SPACE
ffhd-863	9	31	was	be	AUX
ffhd-863	9	32	used	use	VERB
ffhd-863	9	33	as	as	ADP
ffhd-863	9	34	the	the	DET
ffhd-863	9	35	active	active	ADJ
ffhd-863	9	36	sample	sample	NOUN
ffhd-863	9	37	.	.	PUNCT
ffhd-863	10	1	we	we	PRON
ffhd-863	10	2	enrolled	enrol	VERB
ffhd-863	10	3	44	44	NUM
ffhd-863	10	4	healthy	healthy	ADJ
ffhd-863	10	5	japanese	japanese	ADJ
ffhd-863	10	6	men	man	NOUN
ffhd-863	10	7	and	and	CCONJ
ffhd-863	10	8	women	woman	NOUN
ffhd-863	10	9	with	with	ADP
ffhd-863	10	10	6.0	6.0	NUM
ffhd-863	10	11	to	to	PART
ffhd-863	10	12	7.9	7.9	NUM
ffhd-863	10	13	mg	mg	PROPN
ffhd-863	10	14	/	/	SYM
ffhd-863	10	15	dl	dl	PROPN
ffhd-863	10	16	serum	serum	PROPN
ffhd-863	10	17	uric	uric	ADJ
ffhd-863	10	18	acid	acid	NOUN
ffhd-863	10	19	.	.	PUNCT
ffhd-863	11	1	all	all	DET
ffhd-863	11	2	subjects	subject	NOUN
ffhd-863	11	3	were	be	AUX
ffhd-863	11	4	randomly	randomly	ADV
ffhd-863	11	5	allocated	allocate	VERB
ffhd-863	11	6	to	to	ADP
ffhd-863	11	7	an	an	DET
ffhd-863	11	8	active	active	ADJ
ffhd-863	11	9	group	group	NOUN
ffhd-863	11	10	(	(	PUNCT
ffhd-863	11	11	n=22	n=22	PROPN
ffhd-863	11	12	)	)	PUNCT
ffhd-863	11	13	or	or	CCONJ
ffhd-863	11	14	 	 	SPACE
ffhd-863	11	15	placebo	placebo	NOUN
ffhd-863	11	16	group	group	NOUN
ffhd-863	11	17	(	(	PUNCT
ffhd-863	11	18	n=22	n=22	PROPN
ffhd-863	11	19	)	)	PUNCT
ffhd-863	11	20	using	use	VERB
ffhd-863	11	21	a	a	DET
ffhd-863	11	22	computerized	computerized	ADJ
ffhd-863	11	23	random	random	ADJ
ffhd-863	11	24	number	number	NOUN
ffhd-863	11	25	generator	generator	NOUN
ffhd-863	11	26	.	.	PUNCT
ffhd-863	12	1	in	in	ADP
ffhd-863	12	2	the	the	DET
ffhd-863	12	3	purine	purine	NOUN
ffhd-863	12	4	base	base	NOUN
ffhd-863	12	5	absorption	absorption	NOUN
ffhd-863	12	6	study	study	NOUN
ffhd-863	12	7	,	,	PUNCT
ffhd-863	12	8	cfe	cfe	PROPN
ffhd-863	12	9	was	be	AUX
ffhd-863	12	10	ingested	ingest	VERB
ffhd-863	12	11	with	with	ADP
ffhd-863	12	12	a	a	DET
ffhd-863	12	13	purine	purine	NOUN
ffhd-863	12	14	base	base	NOUN
ffhd-863	12	15	-	-	PUNCT
ffhd-863	12	16	rich	rich	ADJ
ffhd-863	12	17	diet	diet	NOUN
ffhd-863	12	18	and	and	CCONJ
ffhd-863	12	19	serum	serum	VERB
ffhd-863	12	20	uric	uric	ADJ
ffhd-863	12	21	acid	acid	NOUN
ffhd-863	12	22	levels	level	NOUN
ffhd-863	12	23	were	be	AUX
ffhd-863	12	24	measured	measure	VERB
ffhd-863	12	25	chronologically	chronologically	ADV
ffhd-863	12	26	.	.	PUNCT
ffhd-863	13	1	in	in	ADP
ffhd-863	13	2	the	the	DET
ffhd-863	13	3	12	12	NUM
ffhd-863	13	4	-	-	PUNCT
ffhd-863	13	5	week	week	NOUN
ffhd-863	13	6	consecutive	consecutive	ADJ
ffhd-863	13	7	ingestion	ingestion	NOUN
ffhd-863	13	8	study	study	NOUN
ffhd-863	13	9	,	,	PUNCT
ffhd-863	13	10	cfe	cfe	PROPN
ffhd-863	13	11	or	or	CCONJ
ffhd-863	13	12	placebo	placebo	NOUN
ffhd-863	13	13	was	be	AUX
ffhd-863	13	14	administered	administer	VERB
ffhd-863	13	15	between	between	ADP
ffhd-863	13	16	january	january	PROPN
ffhd-863	13	17	and	and	CCONJ
ffhd-863	13	18	april	april	PROPN
ffhd-863	13	19	2021	2021	NUM
ffhd-863	13	20	.	.	PUNCT
ffhd-863	14	1	serum	serum	PROPN
ffhd-863	14	2	uric	uric	ADJ
ffhd-863	14	3	acid	acid	PROPN
ffhd-863	14	4	levels	level	NOUN
ffhd-863	14	5	after	after	ADP
ffhd-863	14	6	12	12	NUM
ffhd-863	14	7	weeks	week	NOUN
ffhd-863	14	8	were	be	AUX
ffhd-863	14	9	assessed	assess	VERB
ffhd-863	14	10	as	as	ADP
ffhd-863	14	11	the	the	DET
ffhd-863	14	12	primary	primary	ADJ
ffhd-863	14	13	outcome	outcome	NOUN
ffhd-863	14	14	,	,	PUNCT
ffhd-863	14	15	and	and	CCONJ
ffhd-863	14	16	uric	uric	ADJ
ffhd-863	14	17	acid	acid	NOUN
ffhd-863	14	18	were	be	AUX
ffhd-863	14	19	measured	measure	VERB
ffhd-863	14	20	before	before	ADP
ffhd-863	14	21	and	and	CCONJ
ffhd-863	14	22	after	after	ADP
ffhd-863	14	23	4	4	NUM
ffhd-863	14	24	weeks	week	NOUN
ffhd-863	14	25	of	of	ADP
ffhd-863	14	26	the	the	DET
ffhd-863	14	27	intervention	intervention	NOUN
ffhd-863	14	28	as	as	ADP
ffhd-863	14	29	secondary	secondary	ADJ
ffhd-863	14	30	outcomes	outcome	NOUN
ffhd-863	14	31	.	.	PUNCT
ffhd-863	15	1	blood	blood	NOUN
ffhd-863	15	2	,	,	PUNCT
ffhd-863	15	3	urine	urine	NOUN
ffhd-863	15	4	and	and	CCONJ
ffhd-863	15	5	body	body	NOUN
ffhd-863	15	6	parameters	parameter	NOUN
ffhd-863	15	7	were	be	AUX
ffhd-863	15	8	examined	examine	VERB
ffhd-863	15	9	to	to	PART
ffhd-863	15	10	evaluate	evaluate	VERB
ffhd-863	15	11	the	the	DET
ffhd-863	15	12	safety	safety	NOUN
ffhd-863	15	13	of	of	ADP
ffhd-863	15	14	cfe	cfe	PROPN
ffhd-863	15	15	.	.	PUNCT
ffhd-863	15	16	  	  	SPACE
ffhd-863	16	1	results	result	NOUN
ffhd-863	16	2	:	:	PUNCT
ffhd-863	16	3	 	 	SPACE
ffhd-863	16	4	thirty	thirty	NUM
ffhd-863	16	5	-	-	PUNCT
ffhd-863	16	6	nine	nine	NUM
ffhd-863	16	7	subjects	subject	NOUN
ffhd-863	16	8	completed	complete	VERB
ffhd-863	16	9	the	the	DET
ffhd-863	16	10	trial	trial	NOUN
ffhd-863	16	11	,	,	PUNCT
ffhd-863	16	12	and	and	CCONJ
ffhd-863	16	13	 	 	SPACE
ffhd-863	16	14	the	the	DET
ffhd-863	16	15	per	per	ADP
ffhd-863	16	16	protocol	protocol	NOUN
ffhd-863	16	17	set	set	VERB
ffhd-863	16	18	comprised	comprise	VERB
ffhd-863	16	19	18	18	NUM
ffhd-863	16	20	and	and	CCONJ
ffhd-863	16	21	21	21	NUM
ffhd-863	16	22	subjects	subject	NOUN
ffhd-863	16	23	in	in	ADP
ffhd-863	16	24	the	the	DET
ffhd-863	16	25	active	active	ADJ
ffhd-863	16	26	and	and	CCONJ
ffhd-863	16	27	placebo	placebo	NOUN
ffhd-863	16	28	groups	group	NOUN
ffhd-863	16	29	,	,	PUNCT
ffhd-863	16	30	respectively	respectively	ADV
ffhd-863	16	31	.	.	PUNCT
ffhd-863	17	1	in	in	ADP
ffhd-863	17	2	the	the	DET
ffhd-863	17	3	single	single	ADJ
ffhd-863	17	4	dosing	dose	VERB
ffhd-863	17	5	study	study	NOUN
ffhd-863	17	6	of	of	ADP
ffhd-863	17	7	cfe	cfe	PROPN
ffhd-863	17	8	on	on	ADP
ffhd-863	17	9	subjects	subject	NOUN
ffhd-863	17	10	loaded	load	VERB
ffhd-863	17	11	by	by	ADP
ffhd-863	17	12	the	the	DET
ffhd-863	17	13	purine	purine	NOUN
ffhd-863	17	14	base	base	NOUN
ffhd-863	17	15	-	-	PUNCT
ffhd-863	17	16	rich	rich	ADJ
ffhd-863	17	17	diet	diet	NOUN
ffhd-863	17	18	,	,	PUNCT
ffhd-863	17	19	no	no	DET
ffhd-863	17	20	significant	significant	ADJ
ffhd-863	17	21	changes	change	NOUN
ffhd-863	17	22	were	be	AUX
ffhd-863	17	23	observed	observe	VERB
ffhd-863	17	24	between	between	ADP
ffhd-863	17	25	the	the	DET
ffhd-863	17	26	cfe	cfe	NOUN
ffhd-863	17	27	and	and	CCONJ
ffhd-863	17	28	placebo	placebo	NOUN
ffhd-863	17	29	groups	group	NOUN
ffhd-863	17	30	.	.	PUNCT
ffhd-863	18	1	on	on	ADP
ffhd-863	18	2	the	the	DET
ffhd-863	18	3	other	other	ADJ
ffhd-863	18	4	hand	hand	NOUN
ffhd-863	18	5	,	,	PUNCT
ffhd-863	18	6	in	in	ADP
ffhd-863	18	7	the	the	DET
ffhd-863	18	8	12	12	NUM
ffhd-863	18	9	-	-	PUNCT
ffhd-863	18	10	week	week	NOUN
ffhd-863	18	11	ingestion	ingestion	NOUN
ffhd-863	18	12	study	study	NOUN
ffhd-863	18	13	,	,	PUNCT
ffhd-863	18	14	serum	serum	NOUN
ffhd-863	18	15	uric	uric	ADJ
ffhd-863	18	16	acid	acid	PROPN
ffhd-863	18	17	levels	level	NOUN
ffhd-863	18	18	were	be	AUX
ffhd-863	18	19	significantly	significantly	ADV
ffhd-863	18	20	lower	low	ADJ
ffhd-863	18	21	in	in	ADP
ffhd-863	18	22	the	the	DET
ffhd-863	18	23	cfe	cfe	PROPN
ffhd-863	18	24	group	group	NOUN
ffhd-863	18	25	than	than	ADP
ffhd-863	18	26	in	in	ADP
ffhd-863	18	27	the	the	DET
ffhd-863	18	28	placebo	placebo	NOUN
ffhd-863	18	29	group	group	NOUN
ffhd-863	18	30	.	.	PUNCT
ffhd-863	19	1	laboratory	laboratory	NOUN
ffhd-863	19	2	tests	test	NOUN
ffhd-863	19	3	revealed	reveal	VERB
ffhd-863	19	4	no	no	DET
ffhd-863	19	5	abnormalities	abnormality	NOUN
ffhd-863	19	6	to	to	PART
ffhd-863	19	7	suggest	suggest	VERB
ffhd-863	19	8	any	any	DET
ffhd-863	19	9	side	side	NOUN
ffhd-863	19	10	effects	effect	NOUN
ffhd-863	19	11	of	of	ADP
ffhd-863	19	12	cfe	cfe	PROPN
ffhd-863	19	13	.	.	PUNCT
ffhd-863	20	1	conclusions	conclusion	NOUN
ffhd-863	20	2	:	:	PUNCT
ffhd-863	20	3	 	 	SPACE
ffhd-863	20	4	cfe	cfe	PROPN
ffhd-863	20	5	 	 	SPACE
ffhd-863	20	6	(	(	PUNCT
ffhd-863	20	7	100	100	NUM
ffhd-863	20	8	mg	mg	NUM
ffhd-863	20	9	/	/	SYM
ffhd-863	20	10	day	day	NOUN
ffhd-863	20	11	)	)	PUNCT
ffhd-863	20	12	containing	contain	VERB
ffhd-863	20	13	1	1	NUM
ffhd-863	20	14	mg	mg	ADP
ffhd-863	20	15	of	of	ADP
ffhd-863	20	16	luteolin	luteolin	PROPN
ffhd-863	20	17	reduced	reduce	VERB
ffhd-863	20	18	serum	serum	PROPN
ffhd-863	20	19	uric	uric	ADJ
ffhd-863	20	20	acid	acid	PROPN
ffhd-863	20	21	levels	level	NOUN
ffhd-863	20	22	.	.	PUNCT
ffhd-863	21	1	cfe	cfe	PROPN
ffhd-863	21	2	may	may	AUX
ffhd-863	21	3	be	be	AUX
ffhd-863	21	4	beneficial	beneficial	ADJ
ffhd-863	21	5	for	for	ADP
ffhd-863	21	6	improving	improve	VERB
ffhd-863	21	7	hyperurichemia	hyperurichemia	NOUN
ffhd-863	21	8	.	.	PUNCT
ffhd-863	21	9	  	  	SPACE
ffhd-863	21	10	trial	trial	NOUN
ffhd-863	21	11	registration	registration	NOUN
ffhd-863	21	12	:	:	PUNCT
ffhd-863	21	13	 	 	SPACE
ffhd-863	21	14	umin	umin	PROPN
ffhd-863	21	15	-	-	PUNCT
ffhd-863	21	16	ctr	ctr	PROPN
ffhd-863	21	17	:	:	PUNCT
ffhd-863	21	18	umin000042327	umin000042327	PROPN
ffhd-863	21	19	foundation	foundation	NOUN
ffhd-863	21	20	:	:	PUNCT
ffhd-863	21	21	 	 	SPACE
ffhd-863	21	22	the	the	DET
ffhd-863	21	23	present	present	ADJ
ffhd-863	21	24	study	study	NOUN
ffhd-863	21	25	was	be	AUX
ffhd-863	21	26	funded	fund	VERB
ffhd-863	21	27	by	by	ADP
ffhd-863	21	28	oryza	oryza	PROPN
ffhd-863	21	29	oil	oil	PROPN
ffhd-863	21	30	&	&	CCONJ
ffhd-863	21	31	fat	fat	PROPN
ffhd-863	21	32	chemical	chemical	PROPN
ffhd-863	21	33	co.	co.	PROPN
ffhd-863	21	34	,	,	PUNCT
ffhd-863	21	35	ltd	ltd	PROPN
ffhd-863	21	36	.	.	PROPN
ffhd-863	21	37	  	  	SPACE
ffhd-863	21	38	keywords	keyword	NOUN
ffhd-863	21	39	:	:	PUNCT
ffhd-863	21	40	 	 	SPACE
ffhd-863	21	41	chrysanthemum	chrysanthemum	NOUN
ffhd-863	21	42	,	,	PUNCT
ffhd-863	21	43	luteolin	luteolin	PROPN
ffhd-863	21	44	,	,	PUNCT
ffhd-863	21	45	uric	uric	ADJ
ffhd-863	21	46	acid	acid	NOUN
ffhd-863	21	47	,	,	PUNCT
ffhd-863	21	48	purine	purine	NOUN
ffhd-863	21	49	base	base	NOUN
ffhd-863	21	50	author	author	NOUN
ffhd-863	21	51	biographies	biography	NOUN
ffhd-863	21	52	tsuyoshi	tsuyoshi	PROPN
ffhd-863	21	53	takara	takara	PROPN
ffhd-863	21	54	,	,	PUNCT
ffhd-863	21	55	takara	takara	PROPN
ffhd-863	21	56	clinic	clinic	PROPN
ffhd-863	21	57	,	,	PUNCT
ffhd-863	21	58	medical	medical	ADJ
ffhd-863	21	59	corporation	corporation	PROPN
ffhd-863	21	60	seishinkai	seishinkai	PROPN
ffhd-863	21	61	md	md	PROPN
ffhd-863	21	62	hiroshi	hiroshi	PROPN
ffhd-863	21	63	shimoda	shimoda	PROPN
ffhd-863	21	64	,	,	PUNCT
ffhd-863	21	65	oryza	oryza	PROPN
ffhd-863	21	66	oil	oil	PROPN
ffhd-863	21	67	&	&	CCONJ
ffhd-863	21	68	fat	fat	PROPN
ffhd-863	21	69	chemical	chemical	PROPN
ffhd-863	21	70	co.	co.	PROPN
ffhd-863	21	71	ltd	ltd	PROPN
ffhd-863	21	72	.	.	PROPN
ffhd-863	22	1	ph.d	ph.d	PROPN
ffhd-863	22	2	.	.	PUNCT
ffhd-863	23	1	manager	manager	NOUN
ffhd-863	23	2	downloads	download	VERB
ffhd-863	24	1	[	[	X
ffhd-863	24	2	abstract	abstract	X
ffhd-863	24	3	]	]	X
ffhd-863	24	4	[	[	X
ffhd-863	24	5	full	full	ADJ
ffhd-863	24	6	article	article	NOUN
ffhd-863	24	7	]	]	PUNCT
ffhd-863	24	8	published	publish	VERB
ffhd-863	24	9	2022	2022	NUM
ffhd-863	24	10	-	-	SYM
ffhd-863	24	11	01	01	NUM
ffhd-863	24	12	-	-	PUNCT
ffhd-863	24	13	10	10	NUM
ffhd-863	24	14	issue	issue	NOUN
ffhd-863	24	15	vol	vol	NOUN
ffhd-863	24	16	.	.	PROPN
ffhd-863	25	1	12	12	NUM
ffhd-863	25	2	no	no	NOUN
ffhd-863	25	3	.	.	NOUN
ffhd-863	25	4	1	1	NUM
ffhd-863	25	5	(	(	PUNCT
ffhd-863	25	6	2022	2022	NUM
ffhd-863	25	7	):	):	PUNCT
ffhd-863	25	8	january	january	PROPN
ffhd-863	25	9	2022	2022	NUM
ffhd-863	25	10	section	section	NOUN
ffhd-863	25	11	research	research	NOUN
ffhd-863	25	12	articles	article	NOUN
ffhd-863	25	13	license	license	NOUN
ffhd-863	25	14	authors	author	NOUN
ffhd-863	25	15	retain	retain	VERB
ffhd-863	25	16	the	the	DET
ffhd-863	25	17	copyright	copyright	NOUN
ffhd-863	25	18	of	of	ADP
ffhd-863	25	19	their	their	PRON
ffhd-863	25	20	articles	article	NOUN
ffhd-863	25	21	and	and	CCONJ
ffhd-863	25	22	grant	grant	VERB
ffhd-863	25	23	the	the	DET
ffhd-863	25	24	functional	functional	ADJ
ffhd-863	25	25	food	food	NOUN
ffhd-863	25	26	center	center	NOUN
ffhd-863	25	27	(	(	PUNCT
ffhd-863	25	28	ffc	ffc	NOUN
ffhd-863	25	29	)	)	PUNCT
ffhd-863	25	30	and	and	CCONJ
ffhd-863	25	31	its	its	PRON
ffhd-863	25	32	journals	journal	NOUN
ffhd-863	25	33	the	the	DET
ffhd-863	25	34	right	right	NOUN
ffhd-863	25	35	of	of	ADP
ffhd-863	25	36	first	first	ADJ
ffhd-863	25	37	publication	publication	NOUN
ffhd-863	25	38	under	under	ADP
ffhd-863	25	39	the	the	DET
ffhd-863	25	40	terms	term	NOUN
ffhd-863	25	41	of	of	ADP
ffhd-863	25	42	the	the	DET
ffhd-863	25	43	creative	creative	ADJ
ffhd-863	25	44	commons	common	NOUN
ffhd-863	25	45	attribution	attribution	NOUN
ffhd-863	25	46	4.0	4.0	NUM
ffhd-863	25	47	international	international	ADJ
ffhd-863	25	48	license	license	NOUN
ffhd-863	25	49	.	.	PUNCT
ffhd-863	26	1	this	this	DET
ffhd-863	26	2	license	license	NOUN
ffhd-863	26	3	permits	permit	VERB
ffhd-863	26	4	unrestricted	unrestricted	ADJ
ffhd-863	26	5	use	use	NOUN
ffhd-863	26	6	,	,	PUNCT
ffhd-863	26	7	distribution	distribution	NOUN
ffhd-863	26	8	,	,	PUNCT
ffhd-863	26	9	and	and	CCONJ
ffhd-863	26	10	reproduction	reproduction	NOUN
ffhd-863	26	11	in	in	ADP
ffhd-863	26	12	any	any	DET
ffhd-863	26	13	medium	medium	NOUN
ffhd-863	26	14	,	,	PUNCT
ffhd-863	26	15	including	include	VERB
ffhd-863	26	16	commercial	commercial	ADJ
ffhd-863	26	17	use	use	NOUN
ffhd-863	26	18	,	,	PUNCT
ffhd-863	26	19	provided	provide	VERB
ffhd-863	26	20	the	the	DET
ffhd-863	26	21	original	original	ADJ
ffhd-863	26	22	author(s	author(s	NOUN
ffhd-863	26	23	)	)	PUNCT
ffhd-863	26	24	and	and	CCONJ
ffhd-863	26	25	source	source	NOUN
ffhd-863	26	26	are	be	AUX
ffhd-863	26	27	properly	properly	ADV
ffhd-863	26	28	credited	credit	VERB
ffhd-863	26	29	.	.	PUNCT
ffhd-863	27	1	authors	author	NOUN
ffhd-863	27	2	may	may	AUX
ffhd-863	27	3	post	post	VERB
ffhd-863	27	4	and	and	CCONJ
ffhd-863	27	5	share	share	VERB
ffhd-863	27	6	their	their	PRON
ffhd-863	27	7	published	publish	VERB
ffhd-863	27	8	work	work	NOUN
ffhd-863	27	9	freely	freely	ADV
ffhd-863	27	10	,	,	PUNCT
ffhd-863	27	11	provided	provide	VERB
ffhd-863	27	12	that	that	SCONJ
ffhd-863	27	13	the	the	DET
ffhd-863	27	14	original	original	ADJ
ffhd-863	27	15	publication	publication	NOUN
ffhd-863	27	16	in	in	ADP
ffhd-863	27	17	this	this	DET
ffhd-863	27	18	journal	journal	NOUN
ffhd-863	27	19	is	be	AUX
ffhd-863	27	20	acknowledged	acknowledge	VERB
ffhd-863	27	21	.	.	PUNCT
ffhd-863	28	1	by	by	ADP
ffhd-863	28	2	submitting	submit	VERB
ffhd-863	28	3	to	to	ADP
ffhd-863	28	4	this	this	DET
ffhd-863	28	5	journal	journal	NOUN
ffhd-863	28	6	,	,	PUNCT
ffhd-863	28	7	authors	author	NOUN
ffhd-863	28	8	confirm	confirm	VERB
ffhd-863	28	9	that	that	SCONJ
ffhd-863	28	10	their	their	PRON
ffhd-863	28	11	manuscripts	manuscript	NOUN
ffhd-863	28	12	are	be	AUX
ffhd-863	28	13	original	original	ADJ
ffhd-863	28	14	,	,	PUNCT
ffhd-863	28	15	not	not	PART
ffhd-863	28	16	under	under	ADP
ffhd-863	28	17	consideration	consideration	NOUN
ffhd-863	28	18	elsewhere	elsewhere	ADV
ffhd-863	28	19	,	,	PUNCT
ffhd-863	28	20	and	and	CCONJ
ffhd-863	28	21	that	that	SCONJ
ffhd-863	28	22	they	they	PRON
ffhd-863	28	23	hold	hold	VERB
ffhd-863	28	24	the	the	DET
ffhd-863	28	25	necessary	necessary	ADJ
ffhd-863	28	26	rights	right	NOUN
ffhd-863	28	27	to	to	PART
ffhd-863	28	28	grant	grant	VERB
ffhd-863	28	29	this	this	DET
ffhd-863	28	30	license	license	NOUN
ffhd-863	28	31	.	.	PUNCT
ffhd-863	29	1	the	the	DET
ffhd-863	29	2	functional	functional	ADJ
ffhd-863	29	3	food	food	NOUN
ffhd-863	29	4	center	center	NOUN
ffhd-863	29	5	encourages	encourage	VERB
ffhd-863	29	6	open	open	ADJ
ffhd-863	29	7	scientific	scientific	ADJ
ffhd-863	29	8	exchange	exchange	NOUN
ffhd-863	29	9	and	and	CCONJ
ffhd-863	29	10	allows	allow	VERB
ffhd-863	29	11	derivative	derivative	ADJ
ffhd-863	29	12	and	and	CCONJ
ffhd-863	29	13	extended	extended	ADJ
ffhd-863	29	14	works	work	NOUN
ffhd-863	29	15	,	,	PUNCT
ffhd-863	29	16	provided	provide	VERB
ffhd-863	29	17	attribution	attribution	NOUN
ffhd-863	29	18	to	to	ADP
ffhd-863	29	19	the	the	DET
ffhd-863	29	20	original	original	ADJ
ffhd-863	29	21	publication	publication	NOUN
ffhd-863	29	22	is	be	AUX
ffhd-863	29	23	maintained	maintain	VERB
ffhd-863	29	24	.	.	PUNCT
ffhd-863	30	1	about	about	ADP
ffhd-863	30	2	the	the	DET
ffhd-863	30	3	journal	journal	NOUN
ffhd-863	30	4	     	     	SPACE
ffhd-863	30	5	editing	edit	VERB
ffhd-863	30	6	services	service	NOUN
ffhd-863	30	7	      	      	SPACE
ffhd-863	30	8	graphical	graphical	ADJ
ffhd-863	30	9	abstract	abstract	ADJ
ffhd-863	30	10	     	     	SPACE
ffhd-863	30	11	journal	journal	NOUN
ffhd-863	30	12	insights	insight	NOUN
ffhd-863	30	13	        	        	SPACE
ffhd-863	30	14	submissions	submission	NOUN
ffhd-863	30	15	        	        	SPACE
ffhd-863	30	16	editorial	editorial	ADJ
ffhd-863	30	17	team	team	NOUN
ffhd-863	30	18	       	       	SPACE
ffhd-863	30	19	privacy	privacy	NOUN
ffhd-863	30	20	statement	statement	NOUN
ffhd-863	30	21	        	        	SPACE
ffhd-863	30	22	contact	contact	NOUN
ffhd-863	30	23	        	        	SPACE
ffhd-863	30	24	current	current	ADJ
ffhd-863	30	25	        	        	SPACE
ffhd-863	30	26	archives	archive	NOUN
ffhd-863	30	27	  	  	SPACE
ffhd-863	30	28	open	open	ADJ
ffhd-863	30	29	journal	journal	NOUN
ffhd-863	30	30	systems	system	NOUN
ffhd-863	30	31	hosting	host	VERB
ffhd-863	30	32	and	and	CCONJ
ffhd-863	30	33	support	support	NOUN
ffhd-863	30	34	by	by	ADP
ffhd-863	30	35	:	:	PUNCT
ffhd-863	30	36	openjournalsystems.com	openjournalsystems.com	X